Ryan J. Watts Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 11 hours ago
Ryan J. Watts has an estimated net worth of at least $65.1 million*, as of yesterday. They own 2.5 million shares of DNLI stock. They have sold 347,973 shares of DNLI stock since 2021, for an estimated $11.7 million.
Ryan J. Watts $DNLI SEC Form 4 Insider Trading
Ryan J. Watts has filed a total of 40 insider trades in $DNLI since 2021. Their most recent trade was a sale of 7,650 shares, made on Jan 07, 2025. Their largest trade was a sale of 40,000 shares, made on Oct 18, 2024. We estimate that they now own 2.5 million shares of $DNLI, worth an estimated $53.4 million.
Insider Trading at $DNLI
There have been a total of 203 insider trades reported at $DNLI since 2021, with 0 shares purchased and 1.3 million shares sold. The most active insider traders in $DNLI stock have been Ryan J. Watts, Carole Ho, and Alexander O. Schuth. The most recent trade was a sale of 2,907 shares reported by Carole Ho (Chief Medical Officer), made on Jan 07, 2025.
History of Insider Stock Trades by Ryan J. Watts
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
DNLI | Sale | 7,650 | Jan 07, 2025 | Jan. 8, 2025, 9:24 p.m. |
DNLI | Sale | 29,266 | Jan 06, 2025 | Jan. 8, 2025, 9:24 p.m. |
DNLI | Sale | 40,000 | Oct 18, 2024 | Oct. 22, 2024, 4:30 p.m. |
DNLI | Sale | 2,260 | Aug 20, 2024 | Aug. 22, 2024, 4:16 p.m. |
DNLI | Sale | 9,589 | Feb 13, 2024 | Feb. 15, 2024, 10:15 p.m. |
DNLI | Sale | 7,818 | Jan 09, 2024 | Jan. 11, 2024, 6:28 p.m. |
DNLI | Sale | 17,483 | Jan 05, 2024 | Jan. 9, 2024, 8:33 p.m. |
DNLI | Sale | 2,309 | Aug 21, 2023 | Aug. 23, 2023, 4:32 p.m. |
DNLI | Sale | 2,526 | Aug 10, 2023 | Aug. 14, 2023, 5:13 p.m. |
DNLI | Sale | 200 | Apr 20, 2023 | April 24, 2023, 7:10 p.m. |
DNLI | Sale | 24,800 | Apr 21, 2023 | April 24, 2023, 7:10 p.m. |
DNLI | Sale | 25,000 | Feb 13, 2023 | Feb. 15, 2023, 8:01 p.m. |
DNLI | Sale | 8,815 | Feb 13, 2023 | Feb. 15, 2023, 8:01 p.m. |
DNLI | Sale | 25,000 | Feb 10, 2023 | Feb. 13, 2023, 8:14 p.m. |
DNLI | Sale | 3,433 | Feb 09, 2023 | Feb. 13, 2023, 8:14 p.m. |
DNLI | Sale | 4,800 | Jan 05, 2023 | Jan. 9, 2023, 10:41 p.m. |
DNLI | Sale | 5,029 | Jan 04, 2023 | Jan. 5, 2023, 10:07 p.m. |
DNLI | Sale | 2,404 | Aug 19, 2022 | Aug. 23, 2022, 4:48 p.m. |
DNLI | Sale | 9,491 | Feb 11, 2022 | Feb. 15, 2022, 7:58 p.m. |
DNLI | Sale | 2,719 | Feb 09, 2022 | Feb. 10, 2022, 8 p.m. |
DNLI | Sale | 5,007 | Jan 05, 2022 | Jan. 6, 2022, 8 p.m. |
DNLI | Sale | 8,516 | Dec 01, 2021 | Dec. 3, 2021, 5:23 p.m. |
DNLI | Sale | 9,012 | Dec 01, 2021 | Dec. 3, 2021, 5:23 p.m. |
DNLI | Sale | 805 | Dec 01, 2021 | Dec. 3, 2021, 5:23 p.m. |
DNLI | Sale | 1,659 | Nov 01, 2021 | Nov. 2, 2021, 8 p.m. |
DNLI | Sale | 16,674 | Nov 01, 2021 | Nov. 2, 2021, 8 p.m. |
DNLI | Sale | 3,304 | Oct 01, 2021 | Oct. 4, 2021, 8 p.m. |
DNLI | Sale | 4,247 | Oct 01, 2021 | Oct. 4, 2021, 8 p.m. |
DNLI | Sale | 10,782 | Oct 01, 2021 | Oct. 4, 2021, 8 p.m. |
DNLI | Sale | 1,626 | Aug 19, 2021 | Aug. 22, 2021, 8 p.m. |
DNLI | Sale | 750 | Aug 19, 2021 | Aug. 22, 2021, 8 p.m. |
DNLI | Sale | 9,790 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
DNLI | Sale | 8,543 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
DNLI | Sale | 3,030 | Jul 01, 2021 | July 5, 2021, 8 p.m. |
DNLI | Sale | 2,459 | Jul 01, 2021 | July 5, 2021, 8 p.m. |
DNLI | Sale | 12,844 | Jul 01, 2021 | July 5, 2021, 8 p.m. |
DNLI | Sale | 354 | Jun 01, 2021 | June 2, 2021, 8 p.m. |
DNLI | Sale | 2,750 | Jun 01, 2021 | June 2, 2021, 8 p.m. |
DNLI | Sale | 13,127 | Jun 01, 2021 | June 2, 2021, 8 p.m. |
DNLI | Sale | 2,102 | Jun 01, 2021 | June 2, 2021, 8 p.m. |
$DNLI Executives and Stock Owners with Insider Trades
-
Ryan J. Watts, President and CEO
-
Carole Ho, Chief Medical Officer
-
Alexander O. Schuth, COFO and Secretary
-
Alexander O. Schuth, COO and Secretary
-
Steve E. Krognes, CFO and Treasurer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.